Optimizing longevity isn’t just about adding years to the lifespan. It’s about maximizing the healthspan, the amount of time we live in good health, free from significant chronic disease or disability. The human body is rich with clues about what that healthspan might look like, many of them contained within biological markers, or biomarkers, that can be measured in blood, body fluids, or tissues. These markers serve as indicators of both normal biological function and disease processes, providing valuable insight into an individual’s health status. While that information is useful to anyone focused on achieving optimal health, it is of particular importance to women.
Biomarkers and Women’s Health
Women, on average, tend to outlive men. In the U.S., the longevity gap sits at 5.8 years, with women expected to live to 81 while men’s life expectancy is just under 76. But although women can expect a longer lifespan, their healthspan does not always keep pace.
A recent study published in The Lancet Public Health found that while women outlive men worldwide, they are more likely to experience chronic pain and mental health issues.
Data from 204 countries and territories showed women experience higher rates of back pain, depression, anxiety, dementia, headaches, and joint problems, while men are at higher risk of dying prematurely from heart disease, accidents, and other acute causes. The disproportionately longer period of poor health that many women experience can potentially be addressed through the use of biomarkers to detect disease earlier, monitor treatment response, guide adjustments in care, and assess the efficacy and safety of new therapies during clinical trials.
Biomarkers also provide insight into health risks that disproportionately affect women. Heart disease can be measured through cholesterol levels, cardiovascular risk through blood pressure measurements, diabetes through elevated blood glucose levels, and certain cancers through genetic markers such as BRCA1 and BRCA2. By evaluating biomarkers related to reproductive, thyroid, and metabolic health, patients and their healthcare teams can gain valuable insight into both current and future health status, enabling more informed treatment decisions.
They can also get the information they need faster. A recent sex- and gender-stratified study of 6.9 million people in Denmark found that women were diagnosed later than men across a range of diseases, including cancer (an average of 2.5 years later) and metabolic diseases (4.5 years later). The gap widened even further for hormonal and autoimmune conditions, where early intervention can have a significant impact on outcomes. One example cited was perimenopause, during which researchers noted that women experiencing symptoms such as fatigue, mood changes, and weight fluctuations were frequently evaluated for depression or anxiety before hormonal shifts were considered.
Types of Biomarkers
Using biomarkers to improve diagnostic accuracy and reduce delays in care may seem like an obvious solution to the diagnosis gender gap. However, biomarkers serve a wide range of purposes in both clinical practice and research and can generally be classified into several categories:
Diagnostic Biomarkers: Help detect or confirm the presence of a disease or medical condition.
Prognostic Biomarkers: Provide information about likely disease progression, helping predict patient outcomes.
Predictive Biomarkers: Indicate how a patient may respond to a specific treatment, supporting personalized medicine approaches.
Monitoring Biomarkers: Assess disease status over time and help evaluate treatment effectiveness or disease progression.
Susceptibility or Risk Biomarkers: Predict an individual’s likelihood of developing a disease, often based on genetic factors.
Pharmacodynamic Response Biomarkers: Indicate whether a biological response has occurred following exposure to a medication.
Understanding how biomarkers can be used to improve women’s healthspan is just one of the topics that will be explored at A4M’s 2026 Women’s Health Summit: From Perimenopause to the Power Years in San Antonio, Texas, this autumn.
Designed for clinicians advancing the future of women’s health, the summit will bring together physicians, NPs, PAs, OB-GYN clinicians, functional medicine providers, hormone specialists, longevity medicine practitioners, and other healthcare professionals focused on midlife, metabolic, and longevity-centered care.
Among the key topics, attendees will learn how to translate aging biomarkers into actionable clinical strategies that can enhance patient healthspan and reduce the risks that often complicate aging for women. Additional sessions will explore topics such as Healthspan vs. Lifespan: Designing Protocols for Sustainable Vitality, Immune Resilience, and Inflammation Management in Midlife, and Epigenetic Resilience: Protecting DNA Through Midlife and Beyond.
The three-day conference examines health, well-being, and longevity through the lens of women’s health, offering opportunities to learn, connect, and recharge before bringing the latest evidence-based longevity concepts back to clinical practice.
Sources: The Center for Healthy Aging in Women Women's Health: Hormonal and Reproductive Biomarkers Best Biomarkers For Longevity And Health Span Women Outlive Men by 5 Years. Here's How to Close the Gap The Women's Health Summit 2026